ANN ARBOR, MI--(Marketwire - November 14, 2007) - Pipex Pharmaceuticals, Inc. (AMEX: PP), a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of neurologic and fibrotic diseases, announced today its results and achievements for the three and nine month periods ended September 30, 2007. Pipex will also hold a conference call on Thursday, November 15, 2007 at 8:30 a.m. EST to discuss results of elevated levels of free copper in Alzheimer’s disease patients generated with the FreeBound device along with the third quarter 2007 highlights and financial results. Steve H. Kanzer, Chairman and Chief Executive Officer of Pipex, will host the call.
